{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:55:49Z","timestamp":1792418149902,"version":"4.4.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3605500"],"award-info":[{"award-number":["2023YFC3605500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3605503"],"award-info":[{"award-number":["2023YFC3605503"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"CAMS","doi-asserted-by":"publisher","award":["2024-I2M-C&T-B-001"],"award-info":[{"award-number":["2024-I2M-C&T-B-001"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"CAMS","doi-asserted-by":"publisher","award":["2025-I2M-XHXX-018"],"award-info":[{"award-number":["2025-I2M-XHXX-018"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["UBJ11228"],"award-info":[{"award-number":["UBJ11228"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["UBJ10800"],"award-info":[{"award-number":["UBJ10800"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["UHB11957"],"award-info":[{"award-number":["UHB11957"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiopathic multicentric Castleman disease\u2013thrombocytopenia, anasarca, myelofibrosis, renal dysfunction and organomegaly syndrome (iMCD-TAFRO) is a clinically aggressive subtype. Renal involvement and its impact on prognosis are poorly characterized. We aimed to describe renal clinicopathological features and outcomes in a large iMCD-TAFRO cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This 10-year retrospective cohort study enrolled iMCD-TAFRO patients at Peking Union Medical College Hospital. Renal involvement was defined by iMCD consensus criteria. Survival was analyzed using Kaplan\u2013Meier methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 48 patients (70.8% male; mean age 45\u00a0\u00b1\u00a015 years) were included. Renal involvement was observed in 95.8% (46\/48) of the patients, presenting predominantly with reduced urine output, mild hematuria and proteinuria, as well as elevated serum creatinine. Acute kidney injury (AKI) occurred in 80.4% (37\/46) of patients showing renal involvement and 37.8% of them required renal replacement therapy. Renal biopsies (n\u00a0=\u00a07) revealed glomerular microangiopathy in six cases. AKI was associated with elevated C-reactive protein (CRP) and D-dimer levels, and CRP levels correlated with peak serum creatinine levels. Therapy targeting the iMCD was mainly bortezomib, cyclophosphamide and dexamethasone regimen (31\/48, 64.6%) with\/without anti-interleukin-6 therapy. Nine patients died within hospital or during follow-up. Among AKI patients, 28\/37 (75.7%) showed full recovery of renal function. Despite worse renal function at baseline, no significant survival difference was observed between dialyzed and non-dialyzed patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Renal involvement in iMCD-TAFRO is common and frequently manifests as AKI associated with systemic inflammation. Early and aggressive therapy combined with supportive renal care, including timely dialysis, improved renal recovery and overall prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag326","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:45:25Z","timestamp":1789213525000},"source":"Crossref","is-referenced-by-count":0,"title":["Kidney involvement in idiopathic multicentric Castleman disease\u2013TAFRO syndrome: clinical spectrum, pathology and outcomes"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8171-2779","authenticated-orcid":false,"given":"Shuo","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8834-5067","authenticated-orcid":false,"given":"Fei","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4549-0694","authenticated-orcid":false,"given":"Jian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8425-5742","authenticated-orcid":false,"given":"Limeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"2026101909255888400_bib1","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"key":"2026101909255888400_bib2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","article-title":"Castleman disease","volume":"7","author":"Carbone","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026101909255888400_bib3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/JBM.S127822","article-title":"TAFRO syndrome: current perspectives","volume":"9","author":"Sakashita","year":"2018","journal-title":"J Blood Med"},{"key":"2026101909255888400_bib4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ajh.25554","article-title":"Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?","volume":"94","author":"Fujimoto","year":"2019","journal-title":"Am J Hematol"},{"key":"2026101909255888400_bib5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.17305\/bjbms.2017.1930","article-title":"TAFRO syndrome: new subtype of idiopathic multicentric Castleman disease","volume":"17","author":"Srkalovic","year":"2017","journal-title":"Bosn J Basic Med Sci"},{"key":"2026101909255888400_bib6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5414\/CN110290","article-title":"Renal histological continuum of TAFRO syndrome: a case report and literature review","volume":"97","author":"Uemura","year":"2022","journal-title":"Clin Nephrol"},{"key":"2026101909255888400_bib7","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.3390\/ijms22126286","article-title":"TAFRO syndrome with renal thrombotic microangiopathy: insights into the molecular mechanism and treatment opportunities","volume":"22","author":"Tu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026101909255888400_bib8","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.ekir.2020.05.004","article-title":"The clinical and histopathological feature of renal manifestation of TAFRO syndrome","volume":"5","author":"Mizuno","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2026101909255888400_bib9","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"key":"2026101909255888400_bib10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/ajh.2629211","article-title":"Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease","volume":"96","author":"Nishimura","year":"2021","journal-title":"Am J Hematol"},{"key":"2026101909255888400_bib11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3760\/cma.j.issn.0253-2727.2021.07.001","article-title":"The consensus of the diagnosis and treatment of Castleman disease in China","volume-title":"Chinese Journal of Hematology","author":"Zhonghua","year":"2021"},{"key":"2026101909255888400_bib12","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kellum","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"2026101909255888400_bib13","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.kint.2020.08.006","article-title":"Consensus definitions for glomerular lesions by light and electron microscopy: recommendations from a working group of the Renal Pathology Society","volume":"98","author":"Haas","year":"2020","journal-title":"Kidney Int"},{"key":"2026101909255888400_bib14","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"2026101909255888400_bib15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10157-024-02573-9","article-title":"Renal involvement in TAFRO syndrome: a review","volume":"29","author":"Ubara","year":"2025","journal-title":"Clin Exp Nephrol"},{"key":"2026101909255888400_bib16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12882-019-1574-9","article-title":"TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review","volume":"20","author":"Nagayama","year":"2019","journal-title":"BMC Nephrol"},{"key":"2026101909255888400_bib17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12882-022-02660-7","article-title":"To and TAFRO\u2014a cryptic cause of acute renal failure: a case report","volume":"23","author":"Shah","year":"2022","journal-title":"BMC Nephrol"},{"key":"2026101909255888400_bib18","first-page":"e8216","article-title":"Clinicopathological features of progressive renal involvement in TAFRO syndrome: a case report and literature review","volume":"96","author":"Tanaka","year":"2017","journal-title":"Medicine (United States)"},{"key":"2026101909255888400_bib19","first-page":"1489","article-title":"Renal pathologic findings in TAFRO syndrome: is there a continuum between thrombotic microangiopathy and membranoproliferative glomerulonephritis? A case report and literature review","volume-title":"Front Immunol","author":"Leurs","year":"2019"},{"key":"2026101909255888400_bib20","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.1038\/s41467-025-61214-1","article-title":"Spatial and single cell mapping of castleman disease reveals key stromal cell types and cytokine pathways","volume":"16","author":"Smith","year":"2025","journal-title":"Nat Commun"},{"key":"2026101909255888400_bib21","doi-asserted-by":"publisher","first-page":"100782","DOI":"10.1016\/j.modpat.2025.100782","article-title":"The involvement of PI3K\u2013Akt signaling in the clinical and pathological findings of idiopathic multicentric Castleman disease\u2013thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly and not otherwise specified subtypes","volume":"38","author":"Haratake","year":"2025","journal-title":"Mod Pathol"},{"key":"2026101909255888400_bib22","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/biomedicines12051076","article-title":"Unraveling TAFRO syndrome: an in-depth look at the pathophysiology, management, and future perspectives","volume":"12","author":"Caballero","year":"2024","journal-title":"Biomedicines"},{"key":"2026101909255888400_bib23","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/BIOMEDICINES","article-title":"Increase in vascular endothelial growth factor (VEGF) expression and the pathogenesis of iMCD-TAFRO","volume":"12","author":"Srkalovic","year":"2024","journal-title":"Biomedicines"},{"key":"2026101909255888400_bib24","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1111\/j.1523-1755.2004.00621.x","article-title":"The role of vascular endothelial growth factor (VEGF) in renal pathophysiology","volume":"65","author":"Schrijvers","year":"2004","journal-title":"Kidney Int"},{"key":"2026101909255888400_bib25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-physiol-021115-105412","article-title":"Vascular growth factors and glomerular disease","volume":"78","author":"Bartlett","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"2026101909255888400_bib26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41581-025-01025-1","article-title":"Cell\u2013cell crosstalk in kidney health and disease","volume":"22","author":"Scheidereit","year":"2026","journal-title":"Nat Rev Nephrol"},{"key":"2026101909255888400_bib27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J Clin Invest"},{"key":"2026101909255888400_bib28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume-title":"N Engl J Med","author":"Eremina","year":"2008"},{"key":"2026101909255888400_bib29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.amjms.2023.09.005","article-title":"Immunoregulation mechanism of VEGF signaling pathway inhibitors and its efficacy on the kidney","volume":"366","author":"Li","year":"2023","journal-title":"Am J Med Sci"},{"key":"2026101909255888400_bib30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","article-title":"Siltuximab for multicentric Castleman\u2019s disease: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Van\u00a0Rhee","year":"2014","journal-title":"Lancet Oncol"},{"key":"2026101909255888400_bib31","first-page":"2654","article-title":"A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD","volume":"141","author":"Zhao","year":"2023","journal-title":"Blood"},{"key":"2026101909255888400_bib32","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1080\/10428194.2021.1999437","article-title":"A prospective, multicenter study of bortezomib, cyclophosphamide, and dexamethasone in relapsed\/refractory iMCD","volume":"63","author":"Zhang","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"2026101909255888400_bib33","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00277-025-06329-7","article-title":"Real-world data of siltuximab for Chinese patients with iMCD: combination with BCD regimen as a potential approach for severe cases","volume":"104","author":"Li","year":"2025","journal-title":"Ann Hematol"},{"key":"2026101909255888400_bib34","first-page":"1","article-title":"Chinese experts consensus on diagnosis, treatment and management of critically ill patients in hematology intensive care unit(2025)","volume":"38","author":"Hu","year":"2025","journal-title":"J Clin Hematol"},{"key":"2026101909255888400_bib35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: current understanding, key questions, and knowledge gaps","volume":"27","author":"Rabb","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2026101909255888400_bib36","doi-asserted-by":"publisher","first-page":"e70026","DOI":"10.1111\/jcmm.70026","article-title":"A hypothesis on treatment strategy of severe multicentric Castleman disease with continuous renal replacement therapy","volume":"28","author":"Constantinescu","year":"2024","journal-title":"J Cell Mol Med"},{"key":"2026101909255888400_bib37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12185-021-03159-x","article-title":"Patients age and D-dimer levels predict the prognosis in patients with TAFRO syndrome","volume-title":"Int J Hematol","author":"Kawabata","year":"2021"},{"key":"2026101909255888400_bib38","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/biomedicines12061328","article-title":"Increase in Vascular Endothelial Growth Factor (VEGF) Expression and the Pathogenesis of iMCD-TAFRO","volume-title":"Biomedicines","author":"Srkalovic","year":"2024"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag326\/71073987\/sfag326.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag326\/71073987\/sfag326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/10\/sfag326\/71073987\/sfag326.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:26:34Z","timestamp":1792416394000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag326\/8793615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag326","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,14]]},"article-number":"sfag326"}}